Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #94826 on Biotech Values
DewDiligence
04/27/10 2:48 PM
#94831 RE: genisi #94826
Gilead anticipates submitting a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the fixed-dose combination following validation of the TMC278 NDA.